s): ? Akubio, in collaboration with USAMRIID (Fort Detrick) intend to 1. Determine whether acoustic detection can differentiate between non-pathogenic and """"""""priority"""""""" pathogenic organisms that are a threat to human health. An initial investigation into the use of acoustic detection for the rapid identification and quantization of a virus, a bacterium and a toxin, selected from the NIAID Category A, B or C list will be carried out. This work will establish performance baselines for the existing detection technology in the area of biodefense pathogen and toxin detection. 2. Apply acoustic detection to direct detection of pathogenic nucleic acid via hybridization of this material to specific oligonucleotide probes.
The aim i s to develop a direct, label-free method to detect pathogenic particles, antigens and nucleic acids simultaneously leading to a substantial reduction in assay time. 3. Develop multiplexed instrumentation and consumables to permit simultaneous testing for multiple agents. This will be achieved with an array of acoustic sensors used together, appropriate antibodies, and nucleic acid probes against a range of Category A, B or C pathogens. Profiles for antigen binding and nucleotide binding to appropriate receptors on the array will be obtained for specific pathogens. 4. Assess and establish the feasibility for production of a small portable device. The performance of this prototype will be compared rigorously with the laboratory-based instrumentation. A product specification and project plan for commercial development and manufacture of this hand-held unit will be produced. ? ?

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-GB-M (M1))
Program Officer
Korpela, Jukka K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Akubio, Ltd
United Kingdom
Zip Code
CB4 0-GJ
Li, Xin; Cooper, Matthew A (2012) Measurement of drug lipophilicity and pKa using acoustics. Anal Chem 84:2609-13
Natesan, Mohan; Cooper, Matthew A; Tran, Julie P et al. (2009) Quantitative detection of staphylococcal enterotoxin B by resonant acoustic profiling. Anal Chem 81:3896-902
Li, Xin; Abell, Christopher; Cooper, Matthew A (2008) Single-step biocompatible coating for sulfhydryl coupling of receptors using 2-(pyridinyldithio)ethylcarbamoyl dextran. Colloids Surf B Biointerfaces 61:113-7
Uludag, Yildiz; Li, Xin; Coleman, Heather et al. (2008) Direct acoustic profiling of DNA hybridisation using HSV type 1 viral sequences. Analyst 133:52-7
Godber, Benjamin; Frogley, Mark; Rehak, Marian et al. (2007) Profiling of molecular interactions in real time using acoustic detection. Biosens Bioelectron 22:2382-6
Cooper, Matthew A; Singleton, Victoria T (2007) A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions. J Mol Recognit 20:154-84
Huang, Ling; Cooper, Matthew A (2006) Real-time label-free acoustic technology for rapid detection of Escherichia coli O157:H7. Clin Chem 52:2148-51
Li, Xin; Thompson, Kevin S J; Godber, Ben et al. (2006) Quantification of small molecule-receptor affinities and kinetics by acoustic profiling. Assay Drug Dev Technol 4:565-73